Cubist Systematic Strategies, LLC Iovance Biotherapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 75,900 shares of IOVA stock, worth $595,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,900

Previous 104,300 27.23%

Holding current value

$595,056

Previous $836,000 14.83%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $1.55 Million - $4.17 Million	468,821 New	468,821 $3.81 Million
Q2 2023 Aug 14, 2023	SELL	$5.36 - $9.06 $1.31 Million - $2.21 Million	-244,357 Reduced 49.17%	252,622 $1.78 Million
Q1 2023 May 15, 2023	SELL	$5.53 - $8.22 $667,150 - $991,677	-120,642 Reduced 19.53%	496,979 $3.04 Million
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $902,987 - $1.61 Million	160,674 Added 35.16%	617,621 $3.95 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $1.78 Million - $2.45 Million	186,709 Added 69.09%	456,947 $4.38 Million
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $348,303 - $1 Million	54,593 Added 25.32%	270,238 $2.98 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $344,906 - $532,126	27,860 Added 14.84%	215,645 $3.59 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $1.12 Million - $1.87 Million	-67,514 Reduced 26.45%	187,785 $3.59 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $5.17 Million - $6.77 Million	254,257 Added 24400.86%	255,299 $6.3 Million
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $1.59 Million - $3.23 Million	-97,600 Reduced 98.94%	1,042 $27,000
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $2.04 Million - $3.74 Million	71,108 Added 258.26%	98,642 $3.12 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $36,928 - $66,192	-1,317 Reduced 4.56%	27,534 $1.28 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $7.19 Million - $9.4 Million	-259,052 Reduced 89.98%	28,851 $950,000
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $7.83 Million - $11.8 Million	287,903 New	287,903 $7.9 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $422,611 - $840,247	-21,628 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $582,280 - $954,030	-32,439 Reduced 60.0%	21,628 $599,000
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $884,262 - $1.28 Million	49,153 Added 1000.26%	54,067 $984,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $24.52 $168,568 - $422,626	-17,236 Reduced 77.81%	4,914 $120,000
Q1 2019 May 15, 2019	BUY	$8.41 - $11.26 $65,303 - $87,433	7,765 Added 53.98%	22,150 $211,000
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $108,031 - $171,613	14,385 New	14,385 $127,000
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $177,835 - $242,113	-14,284 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $115,700 - $278,538	14,284 New	14,284 $241,000

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.24B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Iovance Biotherapeutics, Inc. Transaction History